Frost & Sullivan recognizes VOCSN, a portable respiratory device manufactured by Bothell, Wash-based Ventec Life Systems, with its 2017 North American Frost & Sullivan Award for New Product Innovation.
The device, which received FDA approval in April 2017, is designed to work in hospital, institutional, transport, and home environments for patients with neuromuscular disease, impaired lung function, spinal cord injury, and pediatric development complications.
It features a critical care ventilator, 6 L/min equivalent oxygen concentrator, Touch Button Cough assist, hospital grade suction, and a high performance nebulizer, and it is built to be fully customizable for each patient.
The New Product Innovation award recognizes the value-added features and benefits of VOCSN, and the increased ROI it gives customers, which, in turn, raises customer acquisition and overall market penetration potential, according to a media release from Frost & Sullivan.
“VOCSN’s battery life of up to 9 hours and weight of 18 lbs makes it both lightweight and portable, facilitating its use in multiple care settings such as hospitals, sub-acute care facilities, long-term care facilities, transport, and patients’ homes,” says Frost & Sullivan Senior Research Analyst Tanvir Jaikishen, in the release.
“It also demonstrates high customizability in treating a range of conditions such as chronic respiratory diseases, autoimmune diseases, and various forms of muscular dystrophy and spinal cord injuries, Jaikishen adds.
[Source(s): Frost & Sullivan, PR Newswire]
